Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
S Walzer,1 K Travers,2 S Rieder,3 E Erazo-Fischer,3 D Matusiewicz41MArS Market Access and Pricing Strategy UG (hb), Weil am Rhein, Germany; 2United Biosource Corporation, Lexington, USA; 3Alcimed GmbH, Cologne, Germany; 4Institute for Health Care Management and Research, Faculty of Economics and Bus...
Main Authors: | Walzer S, Travers K, Rieder S, Erazo-Fischer E, Matusiewicz D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-05-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/homozygous-familial-hypercholesterolemia-hofh-in-germany-an-epidemiolo-a12937 |
Similar Items
-
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01) -
Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
by: Matej Mlinaric, et al.
Published: (2020-10-01) -
Homozygous familial hypercholesterolemia
by: Ravi Kumar Parihar, et al.
Published: (2012-01-01) -
Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
by: Golnaz Vaseghi, et al.
Published: (2021-01-01) -
Homozygous familial hypercholesterolemia with valvulopathy
by: Ashokan Nambiar, et al.
Published: (2019-01-01)